Broadfin Healthcare Master Fund Ltd, 10% Owner at ARATANA THERAPEUTICS, INC. (PETX), sold 890,516 shares at $6.66 ($5.1M) on 2017-11-29, disclosed to the SEC on 2017-12-01.
Open-market sale of $5.1M PETX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.26 | 1,900 | $12K | 0.2% |
| 2 | $6.28 | 300 | $2K | 0.0% |
| 3 | $6.35 | 7,700 | $49K | 1.0% |
| 4 | $6.50 | 50,000 | $325K | 6.4% |
| 5 | $6.55 | 5,751 | $38K | 0.7% |
| 6 | $6.60 | 49,865 |
| $329K |
| 6.5% |
| 7 | $6.66 | 1,000 | $7K | 0.1% |
| 8 | $5.90 | 50,000 | $295K | 5.8% |
| 9 | $5.95 | 50,000 | $298K | 5.9% |
| 10 | $5.95 | 100,000 | $595K | 11.7% |
| 11 | $5.97 | 11,472 | $68K | 1.3% |
| 12 | $6.03 | 100 | $603 | 0.0% |
| 13 | $5.40 | 425,298 | $2.3M | 45.2% |
| 14 | $5.44 | 1,900 | $10K | 0.2% |
| 15 | $5.45 | 50,000 | $273K | 5.4% |
| 16 | $5.47 | 100 | $547 | 0.0% |
| 17 | $5.52 | 5,110 | $28K | 0.6% |
| 18 | $5.53 | 8,020 | $44K | 0.9% |
| 19 | $5.65 | 72,000 | $407K | 8.0% |
| Total | $5.70 avg | 890,516 | $5.1M | 100% |
| Filing → |
| REPH | SELL | 2017-12-14 | $1.5M | — | Filing → |
| REPH | SELL | 2017-12-07 | $1.0M | — | Filing → |
| REPH | SELL | 2017-11-30 | $2.1M | — | Filing → |